This page shows the latest FDA Breakthrough Therapy Designations 2018 news and features for those working in and with pharma, biotech and healthcare.
The US regulator yesterday awarded Concentric Analgesics and its pipeline drug CA-008 in post-surgical pain with an FDA Breakthrough Therapy designation (BTD). ... The Breakthrough Therapy designation is based on phase Ib placebo-controlled clinical
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
No results were found
The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...